Susquehanna International Group, LLP Matinas Bio Pharma Holdings, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.12 - $0.64 $1,650 - $8,803	13,755 New	13,755 $3,000
Q1 2023 May 16, 2023	SELL	$0.39 - $0.6 $5,579 - $8,584	-14,307 Reduced 49.26%	14,734 $6,000
Q4 2022 Feb 14, 2023	BUY	$0.46 - $42.69 $13,358 - $1.24 Million	29,041 New	29,041 $14,000
Q1 2022 May 16, 2022	SELL	$0.5 - $1.06 $29,785 - $63,144	-59,570 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.92 - $1.22 $54,804 - $72,675	59,570 New	59,570 $60,000
Q3 2021 Nov 15, 2021	SELL	$0.67 - $1.51 $8,015 - $18,065	-11,964 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$0.75 - $1.1 $238,715 - $350,115	-318,287 Reduced 96.38%	11,964 $9,000
Q1 2021 May 17, 2021	BUY	$0.96 - $1.74 $291,142 - $527,695	303,273 Added 1124.15%	330,251 $347,000
Q4 2020 Feb 16, 2021	SELL	$0.76 - $1.47 $28,614 - $55,346	-37,651 Reduced 58.26%	26,978 $37,000
Q3 2020 Nov 16, 2020	BUY	$0.67 - $0.96 $43,301 - $62,043	64,629 New	64,629 $50,000
Q2 2020 Aug 14, 2020	SELL	$0.52 - $0.92 $671,534 - $1.19 Million	-1,291,413 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$0.6 - $2.31 $423,667 - $1.63 Million	706,112 Added 120.64%	1,291,413 $775,000
Q4 2019 Feb 14, 2020	BUY	$0.63 - $2.27 $368,739 - $1.33 Million	585,301 New	585,301 $1.33 Million
Q3 2019 Nov 14, 2019	SELL	$0.59 - $0.9 $53,186 - $81,132	-90,147 Closed	0 $0
Q2 2019 Aug 16, 2019	BUY	$0.79 - $1.11 $466 - $656	591 Added 0.66%	90,147 $77,000
Q2 2019 Aug 14, 2019	SELL	$0.79 - $1.11 $132,895 - $186,726	-168,222 Reduced 65.26%	89,556 $77,000
Q1 2019 May 15, 2019	BUY	$0.6 - $1.41 $154,666 - $363,466	257,778 New	257,778 $281,000
Q2 2018 Aug 14, 2018	SELL	$0.42 - $0.74 $7,748 - $13,651	-18,448 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$0.76 - $1.32 $14,020 - $24,351	18,448 New	18,448 $14,000

Others Institutions Holding MTNB

# of Institutions

Shares Held

3.52M

Call Options Held

Put Options Held

View Full List

About Matinas BioPharma Holdings, Inc.

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $130M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

More about MTNB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account